What is BlueOcean?
The tech industry is rapidly growing. BlueOcean Coin allows you to participate in that growth story by directly investing in an asset-backed token that includes the best medtech companies in Switzerland and Europe.
BlueOcean Ventures’ team has invested in 30+ companies of which several have been successfully exited and 9 have been financed through the team’s first fund BlueOcean Ventures I, since 2008. Before launching BlueOcean Ventures I, BlueOcean team successfully held positions in strategy, finance and senior management in large corporations and start-up companies.
What are the value drivers behind the token price of BOV?
The main value drivers behind BOV are the dividends issued to token holders on the exits from portfolio startups, as sale proceeds of those extits are used to buy back investor’s tokens which is essentially 100% profit sharing.
BlueOcean ICO Roadmap
Launch of BlueOcean Ventures I
Launch of the second fund, BlueOcean Ventures II
BlueOcean Ventures II achieves an impressive 48% growth of its portfolio value until end 2017 (audited numbers)
Set up of Special STO Investment Vehicle in Singapore
BlueOcean Ventures II invest in Volumina Medical SA and Luciole Medical AG, Start of the presale of the STO
End of the STO. 100% of the STO net proceeds are invested into BlueOcean Ventures II
BOV token trades on various exchanges and BlueOcean Ventures II has a portfolio of 6 startups
BlueOcean Ventures II has a portfolio of 8 to 12 companies. Initial expected proceed to token holders from first sale of a portfolio company
BlueOcean Ventures II is closed, all remaining assets are distributed to the investors